Phase 2 Lupus Nephritis (LN) trials recruiting now
All Lupus Nephritis (LN) trials, every phase
7
Phase 2 recruiting
Other phases for Lupus Nephritis (LN)
Phase 2 Lupus Nephritis (LN) trials
- A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G
- A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
- A Study to Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active Glomerulonephritis
- Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus
- CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
- Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN
- The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment
Common questions
What does Phase 2 mean?
Is this list complete?
No. For the full record, search ClinicalTrials.gov.